← Open Payments lookup

MEGAN BURKE: Open Payments

NPI 1417559071 · LONG BRANCH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$344 in 12 payments from 9 companies in 2025. Trend: 2023 $604 · 2024 $372 · 2025 $344

Food & beverage: $344
CompanyPaymentsAmount
GlaxoSmithKline, LLC.1$125
Novartis Pharmaceuticals Corporation3$66
Boston Scientific Corporation2$51
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)1$21
Merck Sharp & Dohme LLC1$18
Alnylam Pharmaceuticals Inc.1$18
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
BridgeBio Pharma, Inc.1$14
AstraZeneca Pharmaceuticals LP1$14

Products named: BENLYSTA, LEQVIO, WATCHMAN FLX, LifeVest, VERQUVO, ONPATTRO, Attruby, FARXIGA.

Industry payments across NJ — which companies pay providers there.